Results

Looking for more? ProQuest® Dissertations & Theses has additional dissertations and theses.
32 open access dissertations and theses found for:
if(Dasatinib)  »   Refine Search
1.
Src kinase inhibitors for the treatment of sarcomas: Cellular and molecular mechanisms of action
by Shor, Audrey Cathryn, Ph.D.  University of South Florida. 2007: 211 pages; 3260112.
2.
Cancer Bioinformatics for Biomarker Discovery
by Webber, James Trubek, Ph.D.  University of California, San Francisco. 2017: 316 pages; 10604636.
3.
The Role of Human Ephrin Receptor Tyrosine Kinase A2 (EphA2) in Chlamydia trachomatis Infection
by Subbarayal, Prema, Ph.D.  Bayerische Julius-Maximilians-Universitaet Wuerzburg (Germany). 2015: 135 pages; 10720631.
5.
Furthering the Scope, Understanding, and Application of Proteolysis Targeting Chimera
by Bondeson, Daniel Paul, Ph.D.  Yale University. 2018: 183 pages; 10957227.
6.
Biomarker Based Therapies in High Risk Cancer Patients – MACC1 as Molecular Target
by Zincke, Fabian, Ph.D.  Humboldt Universitaet zu Berlin (Germany). 2019: 138 pages; 27816918.
7.
Optimizing the Sequence of Targeted Therapy in EGFR-Mutant Lung Adenocarcinoma
by Meador, Catherine Belle, Ph.D.  Vanderbilt University. 2015: 243 pages; 13835143.
8.
Single cell characterization of biochemical noise and variable response to chemical inhibition
by Vogel, Robert Michael, Ph.D.  Weill Medical College of Cornell University. 2016: 132 pages; 10007588.
9.
Eph Receptor Signaling Controls Colorectal Carcinoma Cell Proliferation and Survival
by DiPrima, Michael J., Ph.D.  The George Washington University. 2019: 193 pages; 13901095.
10.
Extracellular cues drive integrin mediated signaling to drive cancer cell invasion
by Rubashkin, Matthew, Ph.D.  University of California, San Francisco. 2016: 277 pages; 10100561.
12.
Off-Target Based Drug Repurposing Using Systems Pharmacology
by Kuenzi, Brent M., Ph.D.  University of South Florida. 2018: 182 pages; 10826474.
13.
14.
Immunotherapy and T cell receptor analysis in recurrent type 1 diabetes
by Garland, Alaina Leigh, Ph.D.  The University of North Carolina at Chapel Hill. 2012: 136 pages; 3509265.
15.
Functional analysis of tyrosine residues in human hepatocyte nuclear factor 4alpha
by Chellappa, Karthikeyani, Ph.D.  University of California, Riverside. 2009: 353 pages; 3357009.
16.
Understanding the unique pathways of IBC cell survival and motility
by Joglekar-Javadekar, Madhura, Ph.D.  University of Delaware. 2013: 194 pages; 3594930.
17.
The role of caudal genes in adult hematopoiesis and leukemogenesis
by Koo, Sumin, Ph.D.  Harvard University. 2009: 203 pages; 3385548.
20.
The effects of Dectin-1 stimulation by fungal β-glucans on T cell activation by dendritic cells
by Hassanzadeh-Kiabi, Nargess, Ph.D.  Cedars-Sinai Medical Center. 2016: 125 pages; 10168998.
21.
Einfluss von Indomethacin und Iloprost auf die Proliferation und Differenzierung mesenchymaler Progenitorzellen
by Kemper, Oliver Marvin, Ph.D.  Universitaet Duisburg-Essen (Germany). 2017: 131 pages; 10736785.
22.
The role of the EphB4 receptor tyrosine kinase in lung cancer
by Ferguson, Benjamin David, Ph.D.  The University of Chicago. 2011: 169 pages; 3472845.
23.
Integrin α6 Activity in Castration-Resistant Prostate Cancer
by Nollet, Eric A., Ph.D.  Van Andel Research Institute. 2017: 132 pages; 10289534.
25.
Development of CAPER Peptides for the Treatment of Breast Cancer
by Chilewski, Shannon D., Ph.D.  University of the Sciences in Philadelphia. 2020: 143 pages; 27547515.
26.
A Novel Cytokine Response Modulatory Function of MEK Inhibitors Mediates Therapeutic Efficacy
by Xie, Mengyu, Ph.D.  University of South Florida. 2019: 116 pages; 27548291.
27.
Elucidating warfarin metabolic pathways and developing novel analytical methods paves the way for improving clinical care
by Jones, Drew Rondall Eugene Willie, Ph.D.  University of Arkansas for Medical Sciences. 2011: 190 pages; 3454562.
28.
Clonal evolution in cancer
by Salk, Jesse J., Ph.D.  University of Washington. 2010: 144 pages; 3424283.
29.
EGFR Rearrangements as Oncogenic Drivers and Therapeutic Targets in Lung Cancer
by Gallant, Jean-Nicolas, Ph.D.  Vanderbilt University. 2017: 127 pages; 10753387.
30.
Quorum Sensing in Acute Lymphoblastic Leukemia
by Patel, Sapan J., Ph.D.  Clarkson University. 2016: 313 pages; 10104466.
1 - 30 of 32 displayed.
  1    2   Next >
Copyright © 2020 ProQuest LLC. All rights reserved. Terms and Conditions Privacy Policy Cookie Policy
ProQuest